Primary tabs
Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.
| Revision | Operations | |
|---|---|---|
| 02-7-25 by ripal121 ripal121 replaced Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module. | current revision | |
| 02-7-25 by ripal121 ripal121 replaced Intermittent HD with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module. | ||
| 02-7-25 by conan.macdougal... [email protected] replaced For detailed view of dialysis dosing and evidence, see <a href="https://idmp.ucsfsitebuilder.acsitefactory.com/content/ucsf-adult-antimicrobial-dosing-dialysis-reference-document">Dosing in Hemodialysis</a> document.</p> with via Scanner Search and Replace module. | ||
| 01-7-25 by ripal121 | ||
| 01-7-25 by ripal121 | ||
Dosing: Adult Antimicrobial Dosing, Non-dialysis
| Indication | CrCl ≥ 30 mL/min | CrCl < 30 mL/min |
|---|---|---|
| Prophylaxis in neutropenic fever in patients who are intolerant of fluoroquinolones AND no history of ESBL/CRE organisms | 200 mg po q 12h | 200 mg po q 24h |
Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis
|
Indication |
Intermittent Hemodialysis |
Continuous Hemodialysis |
|---|---|---|
| Prophylaxis in neutropenic fever in patients who are intolerant of fluoroquinolones AND no history of ESBL/CRE organisms | 200 mg x 1 then 200 mg po daily (on days of HD, administer after HD session) | 200 mg po q12h |